【首条AI+个性化靶点肿瘤疫苗生产线亦庄开建】
China’s first AI-powered production line for personalized targeted tumor vaccines has officially broken ground in Beijing. The production line is set to be operational this October. It will help Beijing build an innovation hub for the cell and gene therapy industry.

近日，我国首条AI+个性化靶点肿瘤疫苗生产线在北京经开区正式开建。该生产线属于北京立康生命科技有限公司药物研发及生产中心项目的一部分，预计今年10月竣工投产，将助力北京打造细胞与基因治疗产业创新高地。